RxSight, Inc. to Report First Quarter Financial Results on May 6, 2024
April 22 2024 - 4:05PM
(NASDAQ: RXST) – RxSight, Inc., an ophthalmic
medical device company dedicated to providing high-quality
customized vision to patients following cataract surgery, today
announced that it will report financial results for the first
quarter of 2024 after the market close on Monday, May 6, 2024. The
company’s management will discuss the results during a conference
call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.
To participate in the conference call please
register here. While not required, it is recommended that
participants join ten minutes prior to the event start time to
ensure the necessary audio applications are downloaded and
installed. Instructions are provided (including a dial-in option).
The call will also be available live and archived for one year at
https://investors.rxsight.com/.
About RxSight, Inc.
RxSight, Inc. is an ophthalmic medical device
company dedicated to providing high-quality customized vision to
patients following cataract surgery. The RxSight® Light Adjustable
Lens system, comprised of the RxSight Light Adjustable Lens®
(LAL®/LAL+™), RxSight Light Delivery Device (LDD™) and accessories,
is the first and only commercially available intraocular lens (IOL)
technology that can be adjusted after surgery, enabling doctors to
customize and deliver high-quality vision to patients after
cataract surgery. Additional information about RxSight can be found
at www.rxsight.com.
Company Contact:Shelley B.
ThunenChief Financial Officersthunen@rxsight.com
Investor Relations Contact:Oliver
MoravcevicVP, Investor Relationsomoravcevic@rxsight.com
RxSight (NASDAQ:RXST)
Historical Stock Chart
From Sep 2024 to Oct 2024
RxSight (NASDAQ:RXST)
Historical Stock Chart
From Oct 2023 to Oct 2024